TY - JOUR
T1 - A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
AU - van Zuydam, Natalie R
AU - Ahlqvist, Emma
AU - Ladenvall, Claes
AU - Almgren, Peter
AU - Schulz, Christina-Alexandra
AU - Orho-Melander, Marju
AU - Melander, Olle
AU - Lyssenko, Valeriya
AU - Tuomi, Tiinamaija
AU - Groop, Leif C
AU - McCarthy, Mark I
AU - Finnish Diabetic Nephropathy Study (FinnDiane)
AU - Hong Kong Diabetes Registry Theme-based Research Scheme Project Group
AU - GENIE (Genetics of Nepropathy an International Effort) Consortium
AU - Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
AU - SUMMIT Consortium
AU - Gomez, Maria F
A2 - Kravic, Jasmina
N1 - © 2018 by the American Diabetes Association.
PY - 2018/7
Y1 - 2018/7
N2 - Identification of sequence variants robustly associated with predisposition to diabetic kidney disease (DKD) has the potential to provide insights into the pathophysiological mechanisms responsible. We conducted a genome-wide association study (GWAS) of DKD in type 2 diabetes (T2D) using eight complementary dichotomous and quantitative DKD phenotypes: the principal dichotomous analysis involved 5,717 T2D subjects, 3,345 with DKD. Promising association signals were evaluated in up to 26,827 subjects with T2D (12,710 with DKD). A combined T1D+T2D GWAS was performed using complementary data available for subjects with T1D, which, with replication samples, involved up to 40,340 subjects with diabetes (18,582 with DKD). Analysis of specific DKD phenotypes identified a novel signal near GABRR1 (rs9942471, P = 4.5 × 10-8) associated with microalbuminuria in European T2D case subjects. However, no replication of this signal was observed in Asian subjects with T2D or in the equivalent T1D analysis. There was only limited support, in this substantially enlarged analysis, for association at previously reported DKD signals, except for those at UMOD and PRKAG2, both associated with estimated glomerular filtration rate. We conclude that, despite challenges in addressing phenotypic heterogeneity, access to increased sample sizes will continue to provide more robust inference regarding risk variant discovery for DKD.
AB - Identification of sequence variants robustly associated with predisposition to diabetic kidney disease (DKD) has the potential to provide insights into the pathophysiological mechanisms responsible. We conducted a genome-wide association study (GWAS) of DKD in type 2 diabetes (T2D) using eight complementary dichotomous and quantitative DKD phenotypes: the principal dichotomous analysis involved 5,717 T2D subjects, 3,345 with DKD. Promising association signals were evaluated in up to 26,827 subjects with T2D (12,710 with DKD). A combined T1D+T2D GWAS was performed using complementary data available for subjects with T1D, which, with replication samples, involved up to 40,340 subjects with diabetes (18,582 with DKD). Analysis of specific DKD phenotypes identified a novel signal near GABRR1 (rs9942471, P = 4.5 × 10-8) associated with microalbuminuria in European T2D case subjects. However, no replication of this signal was observed in Asian subjects with T2D or in the equivalent T1D analysis. There was only limited support, in this substantially enlarged analysis, for association at previously reported DKD signals, except for those at UMOD and PRKAG2, both associated with estimated glomerular filtration rate. We conclude that, despite challenges in addressing phenotypic heterogeneity, access to increased sample sizes will continue to provide more robust inference regarding risk variant discovery for DKD.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Case-Control Studies
KW - Diabetes Mellitus, Type 2/complications
KW - Diabetic Nephropathies/epidemiology
KW - Female
KW - Genetic Predisposition to Disease
KW - Genome-Wide Association Study
KW - Humans
KW - Kidney Failure, Chronic/complications
KW - Male
KW - Middle Aged
KW - Polymorphism, Single Nucleotide
KW - Renal Insufficiency, Chronic/complications
U2 - 10.2337/db17-0914
DO - 10.2337/db17-0914
M3 - Article
C2 - 29703844
SN - 1939-327X
VL - 67
SP - 1414
EP - 1427
JO - Diabetes
JF - Diabetes
IS - 7
ER -